KMDA logo

Kamada Ltd.

KMDA
Healthcare|Drug Manufacturers - Specialty & Generic|IL
$7.23
+0.36 (+5.24%)
DCF Value
$35.01
Tangible Book / Share
$2.51
Graham Number
$6.35
Cash / Share
$1.21
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest Sep 9, 2026 (F-3). Possible dilution.

Upcoming Data Readouts (1)

Dec 2027
Est. completion
P4Cytomegalovirus
Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
NCT06958796n=80

Recent Press Releases

Kamada to Announce Third Quarter and Nine Months Ended September 30, 2026, Financial Results on November 9, 2026
Nov 2, 2026 · GlobeNewsWire
Kamada Announces Participation in the Stifel 2026 Healthcare Conference and the Jefferies Global Healthcare Conference in London During November 2026
Oct 19, 2026 · GlobeNewsWire
Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel
Oct 6, 2026 · GlobeNewsWire
CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased Demand
Sep 17, 2026 · GlobeNewsWire
Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 10, 2026 · GlobeNewsWire
Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders
Sep 3, 2026 · GlobeNewsWire
Kamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026
Aug 17, 2026 · GlobeNewsWire
Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada's History; Affirms 2026 Annual Guidance
Aug 12, 2026 · GlobeNewsWire
Kamada Announces Planned Transition of Chief Financial Officer
Aug 12, 2026 · GlobeNewsWire

SEC Filings (54)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 2, 20266-KForeign issuer reportDocumentIndex
Oct 6, 20266-KForeign issuer reportDocumentIndex
Oct 5, 20266-KForeign issuer reportDocumentIndex
Sep 17, 20266-KForeign issuer reportDocumentIndex
Sep 15, 2026EFFECTDocumentIndex
Sep 10, 20266-KForeign issuer reportDocumentIndex
Sep 9, 2026F-3Shelf registrationDocumentIndex
Sep 3, 20266-KForeign issuer reportDocumentIndex
Aug 20, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 17, 20266-KForeign issuer reportDocumentIndex
Aug 12, 20266-KForeign issuer reportDocumentIndex
Aug 5, 20266-KForeign issuer reportDocumentIndex
Aug 5, 20266-KForeign issuer reportDocumentIndex
Jul 20, 20266-KForeign issuer reportDocumentIndex
Jul 13, 20266-KForeign issuer reportDocumentIndex
Jun 18, 20266-KForeign issuer reportDocumentIndex
Jun 1, 20266-KForeign issuer reportDocumentIndex
May 13, 20266-KForeign issuer reportDocumentIndex
May 6, 20266-KForeign issuer reportDocumentIndex
Mar 31, 20266-KForeign issuer reportDocumentIndex
Mar 26, 20266-KForeign issuer reportDocumentIndex
Mar 17, 20266-KForeign issuer reportDocumentIndex
Mar 16, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Mar 11, 202620-FAnnual report (foreign)DocumentIndex
Mar 11, 20266-KForeign issuer reportDocumentIndex
Mar 4, 20266-KForeign issuer reportDocumentIndex
Jan 7, 20266-KForeign issuer reportDocumentIndex
Dec 18, 20256-KForeign issuer reportDocumentIndex
Dec 10, 20256-KForeign issuer reportDocumentIndex
Dec 8, 20256-KForeign issuer reportDocumentIndex
Dec 2, 20256-K/AForeign issuer reportDocumentIndex
Nov 10, 20256-KForeign issuer reportDocumentIndex
Nov 4, 20256-KForeign issuer reportDocumentIndex
Oct 23, 20256-KForeign issuer reportDocumentIndex
Sep 2, 20256-KForeign issuer reportDocumentIndex
Aug 13, 20256-KForeign issuer reportDocumentIndex
Aug 11, 20256-KForeign issuer reportDocumentIndex
Aug 6, 20256-KForeign issuer reportDocumentIndex
Jun 17, 20256-KForeign issuer reportDocumentIndex
Jun 5, 2025SC 13G/APassive 5%+ stakeDocumentIndex